Opportunities

PromarkerD is not available to the public on a commercial basis as yet.

PromarkerD is being developed to be rolled out on a commercial basis by testing laboratories equipped with mass spectrometers (LDT) or by companies equipped to manufacture and distribute the diagnostic test kits (IVD).

Laboratory developed test

PromarkerD has been developed to be delivered by testing laboratories equipped with mass spectrometers.

 

Diagnostic test kits

PromarkerD is being developed to be delivered via an enzyme linked immune-assay (ELISA) kit, also known as an in vitro diagnostic test (IVD) kit.

Companion Diagnostic

PromarkerD is being developed to be used as a companion diagnostic (CDx), assisting physician’s decision making when treating diabetes.